AbSci's Series B Round

AbSci raised a round of funding on April 12, 2016. Investors include Phoenix Venture Partners.

AbSci is focused in protein production technologies committed to reducing costs in the biopharmaceutical industry. The company's SoluPro expression platform achieves yields of soluble and active prote…

Articles about AbSci's Series B Round: